9/10 0 4 0 4 O
donors 5 11 5 11 O
where 12 17 12 17 O
all 18 21 18 21 O
the 22 25 22 25 O
HLA 26 29 26 29 B-clinical_variable
sequences 30 39 30 39 O
have 40 44 40 44 O
the 45 48 45 48 O
same 49 53 49 53 O
antigen 54 61 54 61 B-clinical_variable
/ 61 62 61 62 O
peptide 62 69 62 69 B-clinical_variable
binding 70 77 70 77 O
domains 78 85 78 85 O
in 86 88 86 88 O
key 89 92 89 92 O
exons 93 98 93 98 O
to 99 101 99 101 O
the 102 105 102 105 O
patient 106 113 106 113 O
. 113 114 113 114 O
This 115 119 115 119 O
can 120 123 120 123 O
result 124 130 124 130 O
in 131 133 131 133 O
identical 134 143 134 143 O
protein 144 151 144 151 O
sequences 152 161 152 161 O
between 162 169 162 169 O
patient 170 177 170 177 O
and 178 181 178 181 O
donor 182 187 182 187 O
. 187 188 187 188 O
Allele 189 195 189 195 B-clinical_variable
mismatches 196 206 196 206 O
in 207 209 207 209 O
p 210 211 210 211 O
and 212 215 212 215 O
g 216 217 216 217 O
groups 218 224 218 224 O
can 225 228 225 228 O
be 229 231 229 231 O
considered 232 242 232 242 O
acceptable 243 253 243 253 O
due 254 257 254 257 O
to 258 260 258 260 O
the 261 264 261 264 O
exact 265 270 265 270 O
matching 271 279 271 279 O
which 280 285 280 285 O
exists 286 292 286 292 O
in 293 295 293 295 O
the 296 299 296 299 O
binding 300 307 300 307 O
domains 308 315 308 315 O

Age 0 3 316 319 B-age
greater 4 11 320 327 O
than 12 16 328 332 O
or 17 19 333 335 O
equal 20 25 336 341 O
to 26 28 342 344 O
4 29 30 345 346 B-lower_bound
and 31 34 347 350 O
less 35 39 351 355 O
than 40 44 356 360 O
or 45 47 361 363 O
equal 48 53 364 369 O
to 54 56 370 372 O
80 57 59 373 375 B-upper_bound
years 60 65 376 381 I-upper_bound
old 66 69 382 385 I-upper_bound

Ages 0 4 386 390 B-age
4 5 6 391 392 B-lower_bound
to 7 9 393 395 O
80 10 12 396 398 B-upper_bound
( 13 14 399 400 O
both 14 18 400 404 O
inclusive 19 28 405 414 O
) 28 29 414 415 O
, 29 30 415 416 O
and 31 34 417 420 O
weight 35 41 421 427 B-clinical_variable
> 42 43 428 429 O
18 43 45 429 431 B-lower_bound
kg 45 47 431 433 I-lower_bound

Availability 0 12 434 446 O
of 13 15 447 449 O
HLA 16 19 450 453 O
identical 20 29 454 463 O
or 30 32 464 466 O
single 33 39 467 473 O
HLA 40 43 474 477 O
locus 44 49 478 483 O
mismatched 50 60 484 494 O
family 61 67 495 501 O
donor 68 73 502 507 O
or 74 76 508 510 O
10/10 77 82 511 516 O
matched 83 90 517 524 O
unrelated 91 100 525 534 O
donor 101 106 535 540 O
at 107 109 541 543 O
the 110 113 544 547 O
allelic 114 121 548 555 B-clinical_variable
level 122 127 556 561 I-clinical_variable
( 128 129 562 563 O
HLA 129 132 563 566 O
alleles 133 140 567 574 O
A 141 142 575 576 O
, 142 143 576 577 O
B 144 145 578 579 O
, 145 146 579 580 O
C 147 148 581 582 O
, 148 149 582 583 O
DR 150 152 584 586 O
, 152 153 586 587 O
and 154 157 588 591 O
DQ 158 160 592 594 O
) 160 161 594 595 O

Donors 0 6 596 602 O
with 7 11 603 607 O
HbAS 12 16 608 612 B-clinical_variable
are 17 20 613 616 O
acceptable 21 31 617 627 O

ECOG 0 4 628 632 B-clinical_variable
performance 5 16 633 644 I-clinical_variable
status 17 23 645 651 I-clinical_variable
of 24 26 652 654 O
3 27 28 655 656 B-lower_bound
or 29 31 657 659 O
more 32 36 660 664 O
( 37 38 665 666 O
See 38 41 666 669 O
Bone 42 46 670 674 O
& 47 48 675 676 O
Marrow 49 55 677 683 O
Transplant 56 66 684 694 O
Consortium 67 77 695 705 O
Supportive 78 88 706 716 O
Care 89 93 717 721 O
Guidelines 94 104 722 732 O
for 105 108 733 736 O
HSCT 109 113 737 741 B-treatment
Recipients 114 124 742 752 O
) 124 125 752 753 O

Fanconi 0 7 754 761 B-chronic_disease
s 8 9 762 763 I-chronic_disease
anemia 10 16 764 770 I-chronic_disease

Germline 0 8 771 779 O
/ 8 9 779 780 O
Inherited 9 18 780 789 O
gene 19 23 790 794 O
panel 24 29 795 800 O
in 30 32 801 803 O
patients 33 41 804 812 O
where 42 47 813 818 O
a 48 49 819 820 O
suspicion 50 59 821 830 O
for 60 63 831 834 O
a 64 65 835 836 O
familial 66 74 837 845 B-clinical_variable
bone 75 79 846 850 I-clinical_variable
marrow 80 86 851 857 I-clinical_variable
failure 87 94 858 865 I-clinical_variable
syndrome 95 103 866 874 I-clinical_variable
( 104 105 875 876 I-clinical_variable
BMFS 105 109 876 880 I-clinical_variable
) 109 110 880 881 I-clinical_variable
exists 111 117 882 888 O
, 117 118 888 889 O
hTERC 119 124 890 895 B-clinical_variable
and 125 128 896 899 O
hTERT 129 134 900 905 B-clinical_variable
, 134 135 905 906 O
GATA2 136 141 907 912 O
mutation 142 150 913 921 O
testing 151 158 922 929 O
will 159 163 930 934 O
be 164 166 935 937 O
performed 167 176 938 947 O
on 177 179 948 950 O
protocol 180 188 951 959 O
04 189 191 960 962 O
- 191 192 962 963 O
H-0012 192 198 963 969 O
or 199 201 970 972 O
performed 202 211 973 982 O
elsewhere 212 221 983 992 O
prior 222 227 993 998 O
to 228 230 999 1001 O
enrolling 231 240 1002 1011 O
on 241 243 1012 1014 O
04 244 246 1015 1017 O
- 246 247 1017 1018 O
H-0012 247 253 1018 1024 O

HIV 0 3 1025 1028 B-chronic_disease
positive 4 12 1029 1037 O
( 13 14 1038 1039 O
donors 14 20 1039 1045 O
who 21 24 1046 1049 O
are 25 28 1050 1053 O
positive 29 37 1054 1062 O
for 38 41 1063 1066 O
HBV 42 45 1067 1070 B-chronic_disease
, 45 46 1070 1071 O
HCV 47 50 1072 1075 B-chronic_disease
or 51 53 1076 1078 O
HTLV 54 58 1079 1083 B-chronic_disease
- 58 59 1083 1084 I-chronic_disease
I 59 60 1084 1085 I-chronic_disease
/ 60 61 1085 1086 I-chronic_disease
II 61 63 1086 1088 I-chronic_disease
, 63 64 1088 1089 O
T.cruzi 65 72 1090 1097 B-chronic_disease
[ 73 74 1098 1099 I-chronic_disease
Chagas 74 80 1099 1105 I-chronic_disease
] 80 81 1105 1106 I-chronic_disease
may 82 85 1107 1110 O
be 86 88 1111 1113 O
used 89 93 1114 1118 O
at 94 96 1119 1121 O
the 97 100 1122 1125 O
discretion 101 111 1126 1136 O
of 112 114 1137 1139 O
the 115 118 1140 1143 O
investigator 119 131 1144 1156 O
following 132 141 1157 1166 O
counseling 142 152 1167 1177 O
and 153 156 1178 1181 O
approval 157 165 1182 1190 O
from 166 170 1191 1195 O
the 171 174 1196 1199 O
recipient 175 184 1200 1209 O
) 184 185 1209 1210 O

Left 0 4 1211 1215 B-clinical_variable
ventricular 5 16 1216 1227 I-clinical_variable
ejection 17 25 1228 1236 I-clinical_variable
fraction 26 34 1237 1245 I-clinical_variable
< 35 36 1246 1247 O
40 36 38 1247 1249 B-upper_bound
% 38 39 1249 1250 I-upper_bound
( 40 41 1251 1252 O
evaluated 41 50 1252 1261 O
by 51 53 1262 1264 O
ECHO 54 58 1265 1269 B-treatment
) 58 59 1269 1270 O
or 60 62 1271 1273 O
< 63 64 1274 1275 O
30 64 66 1275 1277 B-upper_bound
% 66 67 1277 1278 I-upper_bound
( 68 69 1279 1280 O
evaluated 69 78 1280 1289 O
by 79 81 1290 1292 O
MUGA 82 86 1293 1297 B-treatment
) 86 87 1297 1298 O

Major 0 5 1299 1304 B-chronic_disease
anticipated 6 17 1305 1316 I-chronic_disease
illness 18 25 1317 1324 I-chronic_disease
or 26 28 1325 1327 O
organ 29 34 1328 1333 B-chronic_disease
failure 35 42 1334 1341 I-chronic_disease
incompatible 43 55 1342 1354 O
with 56 60 1355 1359 O
survival 61 69 1360 1368 O
from 70 74 1369 1373 O
PBSC 75 79 1374 1378 B-treatment
transplant 80 90 1379 1389 I-treatment

Other 0 5 1390 1395 O
malignant 6 15 1396 1405 B-cancer
diseases 16 24 1406 1414 I-cancer
liable 25 31 1415 1421 O
to 32 34 1422 1424 O
relapse 35 42 1425 1432 O
or 43 45 1433 1435 O
progress 46 54 1436 1444 O
within 55 61 1445 1451 O
5 62 63 1452 1453 B-upper_bound
years 64 69 1454 1459 I-upper_bound

Paroxysmal 0 10 1460 1470 B-chronic_disease
nocturnal 11 20 1471 1480 I-chronic_disease
hemoglobinuria 21 35 1481 1495 I-chronic_disease
( 36 37 1496 1497 I-chronic_disease
PNH 37 40 1497 1500 I-chronic_disease
) 40 41 1500 1501 I-chronic_disease
associated 42 52 1502 1512 O
with 53 57 1513 1517 O
life 58 62 1518 1522 O
- 62 63 1522 1523 O
threatening 63 74 1523 1534 O
thrombosis 75 85 1535 1545 B-chronic_disease
, 85 86 1545 1546 O
and/or 87 93 1547 1553 O
cytopenia 94 103 1554 1563 B-chronic_disease
, 103 104 1563 1564 O
and/or 105 111 1565 1571 O
transfusion 112 123 1572 1583 O
dependence 124 134 1584 1594 O
and/or 135 141 1595 1601 O
recurrent 142 151 1602 1611 O
and 152 155 1612 1615 O
debilitating 156 168 1616 1628 O
hemolytic 169 178 1629 1638 O
crisis 179 185 1639 1645 O

Patients 0 8 1646 1654 O
diagnosed 9 18 1655 1664 O
with 19 23 1665 1669 O
one 24 27 1670 1673 O
of 28 30 1674 1676 O
the 31 34 1677 1680 O
following 35 44 1681 1690 O
hematologic 45 56 1691 1702 B-chronic_disease
diseases 57 65 1703 1711 I-chronic_disease
which 66 71 1712 1717 O
are 72 75 1718 1721 O
associated 76 86 1722 1732 O
with 87 91 1733 1737 O
reasonable 92 102 1738 1748 O
longevity 103 112 1749 1758 O
, 112 113 1758 1759 O
shown 114 119 1760 1765 O
to 120 122 1766 1768 O
be 123 125 1769 1771 O
curable 126 133 1772 1779 O
by 134 136 1780 1782 O
allogeneic 137 147 1783 1793 B-treatment
BMT 148 151 1794 1797 I-treatment
but 152 155 1798 1801 O
where 156 161 1802 1807 O
concern 162 169 1808 1815 O
for 170 173 1816 1819 O
a 174 175 1820 1821 O
high 176 180 1822 1826 O
procedural 181 191 1827 1837 O
mortality 192 201 1838 1847 O
with 202 206 1848 1852 O
conventional 207 219 1853 1865 B-treatment
BMT 220 223 1866 1869 I-treatment
may 224 227 1870 1873 O
delay 228 233 1874 1879 O
or 234 236 1880 1882 O
prevent 237 244 1883 1890 O
such 245 249 1891 1895 O
treatment 250 259 1896 1905 O

Pregnant 0 8 1906 1914 B-pregnancy

Presence 0 8 1915 1923 O
of 9 11 1924 1926 O
an 12 14 1927 1929 O
active 15 21 1930 1936 B-chronic_disease
infection 22 31 1937 1946 I-chronic_disease
not 32 35 1947 1950 O
adequately 36 46 1951 1961 O
responding 47 57 1962 1972 O
to 58 60 1973 1975 O
appropriate 61 72 1976 1987 O
therapy 73 80 1988 1995 B-treatment

Refractory 0 10 1996 2006 B-chronic_disease
anemia 11 17 2007 2013 I-chronic_disease
( 18 19 2014 2015 I-chronic_disease
RA 19 21 2015 2017 I-chronic_disease
) 21 22 2017 2018 I-chronic_disease
or 23 25 2019 2021 O
RARS 26 30 2022 2026 B-chronic_disease
MDS 31 34 2027 2030 I-chronic_disease
patients 35 43 2031 2039 O
who 44 47 2040 2043 O
have 48 52 2044 2048 O
associated 53 63 2049 2059 O
transfusion 64 75 2060 2071 B-treatment
dependence 76 86 2072 2082 O
and/or 87 93 2083 2089 O
neutropenia 94 105 2090 2101 B-chronic_disease

Screening 0 9 2102 2111 O
test 10 14 2112 2116 O
positive 15 23 2117 2125 O
for 24 27 2126 2129 O
Chagas 28 34 2130 2136 B-chronic_disease
disease 35 42 2137 2144 I-chronic_disease
( 43 44 2145 2146 O
Trypanosoma 44 55 2146 2157 B-chronic_disease
cruzi 56 61 2158 2163 I-chronic_disease
/T. 62 65 2164 2167 O
cruzi 66 71 2168 2173 I-chronic_disease
/ 71 72 2173 2174 O
trypanosomiasis 72 87 2174 2189 B-chronic_disease
) 87 88 2189 2190 O
confirmed 89 98 2191 2200 O
by 99 101 2201 2203 O
the 102 105 2204 2207 O
Center 106 112 2208 2214 O
for 113 116 2215 2218 O
Disease 117 124 2219 2226 O
Control 125 132 2227 2234 O
( 133 134 2235 2236 O
CDC 134 137 2236 2239 O
) 137 138 2239 2240 O

Serum 0 5 2241 2246 B-clinical_variable
bilirubin 6 15 2247 2256 I-clinical_variable
greater 16 23 2257 2264 O
than 24 28 2265 2269 O
4 29 30 2270 2271 B-lower_bound
mg 31 33 2272 2274 I-lower_bound
/ 33 34 2274 2275 I-lower_bound
dl 34 36 2275 2277 I-lower_bound
, 36 37 2277 2278 O
transaminases 38 51 2279 2292 B-clinical_variable
greater 52 59 2293 2300 O
than 60 64 2301 2305 O
5 65 66 2306 2307 B-lower_bound
times 67 72 2308 2313 I-lower_bound
the 73 76 2314 2317 O
upper 77 82 2318 2323 B-clinical_variable
limit 83 88 2324 2329 I-clinical_variable
of 89 91 2330 2332 I-clinical_variable
normal 92 98 2333 2339 I-clinical_variable

Serum 0 5 2340 2345 B-clinical_variable
creatinine 6 16 2346 2356 I-clinical_variable
greater 17 24 2357 2364 O
than 25 29 2365 2369 O
2.5mg 30 35 2370 2375 B-lower_bound
/ 35 36 2375 2376 I-lower_bound
dl 36 38 2376 2378 I-lower_bound
or 39 41 2379 2381 O
creatinine 42 52 2382 2392 B-clinical_variable
clearance 53 62 2393 2402 I-clinical_variable
less 63 67 2403 2407 O
than 68 72 2408 2412 O
50 73 75 2413 2415 B-upper_bound
ml 76 78 2416 2418 I-upper_bound
/ 78 79 2418 2419 I-upper_bound
min 79 82 2419 2422 I-upper_bound
by 83 85 2423 2425 O
24 86 88 2426 2428 O
hr 89 91 2429 2431 O
urine 92 97 2432 2437 O
collection 98 108 2438 2448 O

Severe 0 6 2449 2455 B-chronic_disease
aplastic 7 15 2456 2464 I-chronic_disease
anemia 16 22 2465 2471 I-chronic_disease
( 23 24 2472 2473 I-chronic_disease
SAA 24 27 2473 2476 I-chronic_disease
) 27 28 2476 2477 I-chronic_disease
or 29 31 2478 2480 O
pure 32 36 2481 2485 B-chronic_disease
red 37 40 2486 2489 I-chronic_disease
cell 41 45 2490 2494 I-chronic_disease
aplasia 46 53 2495 2502 I-chronic_disease
( 54 55 2503 2504 I-chronic_disease
PRCA 55 59 2504 2508 I-chronic_disease
[ 60 61 2509 2510 O
acquired 61 69 2510 2518 O
or 70 72 2519 2521 O
congenital 73 83 2522 2532 O
] 83 84 2532 2533 O
) 84 85 2533 2534 O
associated 86 96 2535 2545 O
with 97 101 2546 2550 O
transfusion 102 113 2551 2562 O
dependence 114 124 2563 2573 O
and/or 125 131 2574 2580 O
neutropenia 132 143 2581 2592 B-treatment
in 144 146 2593 2595 O
patients 147 155 2596 2604 O
who 156 159 2605 2608 O
are 160 163 2609 2612 O
not 164 167 2613 2616 O
candidates 168 178 2617 2627 O
for 179 182 2628 2631 O
, 182 183 2631 2632 O
or 184 186 2633 2635 O
who 187 190 2636 2639 O
have 191 195 2640 2644 O
failed 196 202 2645 2651 O
immunosuppressive 203 220 2652 2669 B-treatment
therapy 221 228 2670 2677 I-treatment

Sickling 0 8 2678 2686 O
hemoglobinopathies 9 27 2687 2705 B-chronic_disease
including 28 37 2706 2715 O
HbSS 38 42 2716 2720 B-chronic_disease
or 43 45 2721 2723 O
HbSC 46 50 2724 2728 B-chronic_disease

Telomere 0 8 2729 2737 B-treatment
Length 9 15 2738 2744 I-treatment
Testing 16 23 2745 2752 I-treatment

The 0 3 2753 2756 O
procedure 4 13 2757 2766 O
will 14 18 2767 2771 O
be 19 21 2772 2774 O
explained 22 31 2775 2784 O
to 32 34 2785 2787 O
subjects 35 43 2788 2796 O
age 44 47 2797 2800 B-age
8 48 49 2801 2802 B-lower_bound
-17 50 53 2803 2806 O
years 54 59 2807 2812 I-upper_bound
with 60 64 2813 2817 O
formal 65 71 2818 2824 O
consent 72 79 2825 2832 O
being 80 85 2833 2838 O
obtained 86 94 2839 2847 O
from 95 99 2848 2852 O
parents 100 107 2853 2860 O
or 108 110 2861 2863 O
legal 111 116 2864 2869 O
guardian 117 125 2870 2878 O

Unfit 0 5 2879 2884 O
to 6 8 2885 2887 O
receive 9 16 2888 2895 O
filgrastim 17 27 2896 2906 B-treatment
( 28 29 2907 2908 I-treatment
G 29 30 2908 2909 I-treatment
- 30 31 2909 2910 I-treatment
CSF 31 34 2910 2913 I-treatment
) 34 35 2913 2914 I-treatment
or 36 38 2915 2917 O
undergo 39 46 2918 2925 O
apheresis 47 56 2926 2935 B-treatment
( 57 58 2936 2937 O
history 58 65 2937 2944 O
of 66 68 2945 2947 O
stroke 69 75 2948 2954 B-chronic_disease
, 75 76 2954 2955 O
MI 77 79 2956 2958 B-chronic_disease
, 79 80 2958 2959 O
unstable 81 89 2960 2968 B-chronic_disease
angina 90 96 2969 2975 I-chronic_disease
, 96 97 2975 2976 O
uncontrolled 98 110 2977 2989 B-chronic_disease
hypertension 111 123 2990 3002 I-chronic_disease
, 123 124 3002 3003 O
severe 125 131 3004 3010 O
heart 132 137 3011 3016 B-chronic_disease
disease 138 145 3017 3024 I-chronic_disease
or 146 148 3025 3027 O
palpable 149 157 3028 3036 B-chronic_disease
spleen 158 164 3037 3043 I-chronic_disease
) 164 165 3043 3044 O

Weight 0 6 3045 3051 B-clinical_variable
> 7 8 3052 3053 O
18 9 11 3054 3056 B-lower_bound
kg 12 14 3057 3059 I-lower_bound

separate 0 8 3060 3068 O
hematologic 9 20 3069 3080 B-cancer
malignancy 21 31 3081 3091 I-cancer
where 32 37 3092 3097 O
allogeneic 38 48 3098 3108 B-treatment
stem 49 53 3109 3113 I-treatment
cell 54 58 3114 3118 I-treatment
transplant 59 69 3119 3129 I-treatment
has 70 73 3130 3133 O
been 74 78 3134 3138 O
shown 79 84 3139 3144 O
to 85 87 3145 3147 O
be 88 90 3148 3150 O
potentially 91 102 3151 3162 O
curative 103 111 3163 3171 O

